ArticleCancers2022
Outcomes Following Abiraterone versus Enzalutamide for Prostate Cancer: A Scoping Review.
Yash B Shah et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
12 papers cite it
this paperpooled itcites it
ArticleCancers2022
Yash B Shah et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.